"The idea of the drug is that it activates the GLP-1 receptors in the brain, which leads to reduction in appetite and weight loss," said Dr
So we use phenotypes, and the most common phenotypes people are probably familiar with is: is your body fat distributed in the upper body segment that belly fat or is it in the lower part of the body
Persistent activation of GLP-1 receptors in exocrine pancreatic cells may lead to localized hyperplasia in the exocrine pancreas, consequently accelerating the formation of dysplastic lesions and pancreatitis [64]
All healthcare decisions, including decisions about starting, stopping, or changing prescription medications, should be made in consultation with a qualified licensed healthcare provider
Diabetologia (1979) 16:7585
doi: 10.1038/s41392-022-01149-x 38